QR kód

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Celý popis

Uloženo v:
Hlavní autoři: Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Médium: Artigo
Jazyk:Inglês
Vydáno: The Journal of Infection in Developing Countries 2024-05-01
Edice:Journal of Infection in Developing Countries
Témata:
Chronic HCV infection
hepatocellular carcinoma
liver cirrhosis
direct-acting antiviral agents
On-line přístup:https://jidc.org/index.php/journal/article/view/18410
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky